Here are the Top Health Story of the day
India reports 58,097 new Covid cases, 534 deaths
Covid-19 continues to rise with increasing threat to global health. India on Wednesday reported 58,097 new cases of Covid, 55% higher than yesterday and active cases increased to 2,14,004, according to union health information.
There are was a rise in new variant omicron as well, a total of 2,135 Omicron cases in India with 23 states reporting a new version of Covid-19. Maharashtra continues to be the country most affected by 653 cases followed by Delhi, with 464 cases.
EWS reservation for medical courses:No clarification needed, says Kerala HCI
Kerala education system changes rules for admission of the animal and dental courses, government has taken measures to not mention quota, to preserve their interests.
The Kerala High Court has ruled that there is no need to further specify the 10 per cent booking offered to the economically disadvantaged categories (EWS) for admission to animal and dental courses through the KEAM Entrance Exam.
Himachal Pradesh NEET Counselling 2021: AMRU Releases Merit Lists For MBBS, BDS Admission
Government allots medical seats every year through NEET admissions to bring young aspiring doctors, in the light of same Atal Medical and Research University (AMRU), Himachal Pradesh, has released a list of eligible HP NEET advisory for state and administrative seats.
The list of regional assignments and administrators includes the names of candidates for admission to the MBBS and BDS courses. AMRU holds the advice of HP NEET 2021 on 85% of the district seats of Himachal Pradesh on behalf of the Department of Medical Education and Research (DMER).
AIIMS cancels doctors' winter vacation; asks to join duty immediately
Doctors being frontline workers in the on going pandemic wanted a break, however it isn't affordable with declining health status in the country.
The All India Institute of Medical Science (AIIMS) on Tuesday announced the cancellation of the winter doctors' holiday amid rising Covid charges.
In a statement issued on Monday, AIIMS Delhi ordered all intelligence members to return to work immediately at the hospital.
IPC Flags Adverse Reaction Linked To Popular COVID Drug Remdesivir
Remdesivir is popular antiviral nucleotide analogue used for therapy of severe novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS) coronavirus 2 (CoV-2) infection, however its safety and adverse effects is yet to be evaluated
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of December, has revealed that popular Covid-19 drug Remdesivir is associated with Adverse Drug Reactions (ADRs) named Sinus Bradycardia.
This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database and a close monitoring is advised.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.